Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections
作者单位:Univ Washington, Dept Bioengn, Box 355061, Seattle, WA 98195 USA[1]Univ Washington, Div Pulm & Crit Care Med, Harborview Med Ctr, Seattle, WA 98104 USA[2]